Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.07 USD | -1.65% | -17.11% | -60.82% |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.59M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.29
x | P/E ratio 2025 * |
-0.43
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.34% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | -1.65% | ||
1 week | -17.11% | ||
Current month | -20.43% | ||
1 month | -21.74% | ||
3 months | -37.04% | ||
6 months | -72.65% | ||
Current year | -60.82% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 5.07 | -1.65% | 12,491 |
24-04-24 | 5.155 | -9.30% | 51,395 |
24-04-23 | 5.683 | +4.28% | 81,950 |
24-04-22 | 5.45 | -11.42% | 197,945 |
24-04-19 | 6.152 | +0.59% | 27,436 |
Delayed Quote Nasdaq, April 25, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.82% | 2.59M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- WINT Stock